RenovoRx News - RNXT

Company Name	Stock Ticker Symbol	Market	Type
RenovoRx Inc	RNXT	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.06	4.96%	1.27	09:36:31

Open Price	Low Price	High Price	Close Price	Prev Close
1.27	1.27	1.27		1.21

more quote information »

Recent News

Date	Time	Source	Heading
4/18/2024	08:30	BW	RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity..
4/16/2024	08:30	BW	RenovoRx Highlights Recent Presentation of Clinical Data..
4/15/2024	08:00	BW	RenovoRx Closes $11.1 Million Private Placement, Providing..
4/08/2024	08:30	BW	RenovoRx Announces $11.1 Million at Market Private Placement
4/05/2024	08:30	BW	RenovoRx to Present at the Canaccord Genuity Horizons in..
3/12/2024	09:00	BW	RenovoRx to Present at the 36th Annual ROTH Conference on..
3/08/2024	16:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/08/2024	16:26	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
3/08/2024	16:05	BW	RenovoRx Highlights Key Leadership Promotions
2/12/2024	19:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	16:30	EDGAR2	Form 8-K - Current report
2/06/2024	08:30	BW	RenovoRx CEO Issues Letter to Shareholders
1/30/2024	19:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/30/2024	18:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/30/2024	18:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/30/2024	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/29/2024	09:06	EDGAR2	Form 8-K - Current report
1/29/2024	08:30	BW	RenovoRx Closes $6.1 Million Private Placement
1/23/2024	21:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/23/2024	21:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/23/2024	21:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	08:30	EDGAR2	Form 8-K - Current report
12/21/2023	08:30	BW	RenovoRx Engages Oklahoma University (OU) Health as First..
12/19/2023	08:30	BW	RenovoRx Announces Clinical Data Abstract at the 2024..
12/18/2023	16:15	EDGAR2	Form 8-K - Current report
12/13/2023	08:31	BW	RenovoRx Files New International Patent for Novel Targeted..
11/27/2023	13:23	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/17/2023	17:30	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/16/2023	08:35	BW	RenovoRx Expands Scientific Advisory Board with Appointment..
11/14/2023	08:30	BW	RenovoRx Reports Third Quarter 2023 Financial Results and..
11/13/2023	16:58	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/2023	16:15	EDGAR2	Form 8-K - Current report
10/04/2023	16:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/02/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/02/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/02/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/02/2023	08:30	BW	RenovoRx to Present at the ROTH MKM Healthcare Opportunities..
8/25/2023	16:15	EDGAR2	Form 8-K - Current report
8/17/2023	08:30	EDGAR2	Form 8-K - Current report
8/17/2023	08:30	BW	RenovoRx Reports Second Quarter 2023 Financial Results and..
8/16/2023	14:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/15/2023	15:57	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
7/31/2023	08:30	BW	RenovoRx to Present at the 43rd Annual Canaccord Genuity..
7/20/2023	08:00	BW	RenovoRx and Imugene Announce Collaboration to Deliver..
6/29/2023	09:27	EDGAR2	Form 8-K - Current report
6/29/2023	08:00	BW	RenovoRx Announces New Positive Interim Phase III Data..
6/20/2023	08:30	BW	RenovoRx Appoints Margaret A. Tempero, M.D., to Scientific..
6/12/2023	08:30	BW	RenovoRx Announces ROTH Capital Key Opinion Leader (KOL)..
6/01/2023	08:30	BW	RenovoRx Initiates Patient Enrollment at University of Texas..
5/25/2023	08:30	BW	RenovoRx Announces Late-Breaking Oral Presentation at 2023..